|
 TWX, Time Warner Inc.
** TWX was upgraded from Neutral to Buy by Brokerage Firm UBS 
TWX operates as a media and entertainment company in the United States and internationally. TWX operates in three segments: Networks, Film and TV Entertainment, and Publishing. More about TWX at www.timewarner.com ***********  OREX, Orexigen Therapeutics, Inc.
** OREX reported anan update to the projected timeframe for enrollment of patients in the Light Study, the cardiovascular outcomes clinical trial evaluating Contrave(R) (naltrexone SR/ bupropion SR). The primary endpoint of the Light Study is the time to occurrence of major adverse cardiovascular events during randomized treatment for Contrave compared to placebo. Enrollment into the study has continued without abatement at a rate faster than originally expected, with more than 4,500 patients enrolled as of August 31. OREX now expects to close enrollment to new patients in the fourth quarter of 2012. 
OREX is a biopharmaceutical company focused on the treatment of obesity. OREX's lead product candidate is Contrave, which has completed Phase III clinical trials and for which a New-Drug Application has been submitted and reviewed by the FDA. More about OREX at www.orexigen.com *********** 
VIDEO is what consumers are looking for, and the best way to out rank, and out perform your competition is by using effective online video marketing strategies.  Crown Equity Holdings Inc., (CRWE) recenly launched CRWE Tube, www.crwetube.com, a video sharing site that allows billions of people around the world to upload, watch and share original videos.
Restricting your marketing to just written text vastly limits your audience; video marketing should be seen as another mode of online communication to reach potential customers. CRWE offers advertising branding and marketing services as a worldwide online multi-media publisher with its digital network of websites and focuses on the distribution of information for the purpose of bringing together a targeted audience and the advertisers that want to reach them. CRWE?s advertising services cover and connect a range of marketing specialties, as well as provide search engine optimization for clients interested in online media awareness. More about CRWE at www.crownequityholdings.com. ******************************** THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyOmega.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyOmega.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://pennyomega.com/disclaimer). Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE) advertises for a particular client, Crown Equity Holdings Inc. (CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE), if paid in stock, can and may sell those securities during the advertising period.
Related Articles -
Orexigen Therapeutics, Nasdaq:OREX, TWX, Time Warner, NYSE:TWX, Crown Equity Holdings, CRWE, Pink:CRWE,
| 
